EUVIMEDEUVIMED entdecken
Crossref

Abstract 17868: The Global Economic Footprint of Cardiomyopathy and Myocarditis: Rising Welfare Losses Across 187 Countries

Damanpartap singh Sandhu, Sankalp Acharya, Dhruvin Patel, Gokul Gopi, Mandeep Kaur, Shrusty Patil, jimik patel, JUHI PATEL, HARDIK D DESAI

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.17868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Damanpartap singh Sandhu und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiomyopathy and myocarditis cause premature health loss across the life course, but their macroeconomic consequences remain poorly quantified. Translating disability-adjusted life-years (DALYs) into value of lost welfare can reveal the hidden economic burden that is not captured by clinical counts alone.

Methods

We analyzed Global Burden of Disease 2023 estimates for cardiomyopathy and myocarditis DALYs in 1990 and 2023 across countries and 1990-2023 across Socio-demographic Index groups and GBD super-regions. Country-level DALYs were linked with World Bank GDP, GDP per capita, GDP purchasing-power-parity (PPP), GDP per capita PPP, and population. Value of lost welfare (VLW) was estimated as DALYs multiplied by GDP per capita PPP and expressed as PPP international dollars and as percentage of GDP PPP. Regional annual percentage change (APC) was estimated using log-linear regression.

Results

Economic data matched 187 countries/territories. Among matched countries, DALYs increased from 8.84 million in 1990 to 11.80 million in 2023 (+33.5%), while VLW rose from $71.6 billion to $321.1 billion (+348.2%). In 2023, aggregate VLW represented 0.175% of GDP PPP. The largest absolute VLW occurred in Russian Federation ($84.2B), United States of America ($55.6B), and India ($21.7B). Relative to GDP, the highest burdens were observed in Latvia (1.397%), Russian Federation (1.299%), and Ukraine (1.054%). Regionally, 2023 DALYs were highest in High SDI (5.35M), Central Europe, Eastern Europe, and Central Asia (3.14M), and South Asia (2.79M), while age-standardized DALY rates were highest in Central Europe, Eastern Europe, and Central Asia (569.4/100,000), Sub-Saharan Africa (232.4/100,000), and Low SDI (214.7/100,000).

Conclusion

Cardiomyopathy and myocarditis impose a substantial and rising macroeconomic burden, with absolute welfare losses concentrated in large economies but the greatest GDP-relative losses occurring in vulnerable settings. These findings support earlier detection, prevention of cardiometabolic and infectious drivers, and health-system investment to reduce avoidable welfare loss.

Zitieren

APA

Sandhu, D. S., Acharya, S., Patel, D., Gopi, G., Kaur, M., Patil, S., patel, J., PATEL, J., & DESAI, H. D. (2026). Abstract 17868: The Global Economic Footprint of Cardiomyopathy and Myocarditis: Rising Welfare Losses Across 187 Countries. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.17868

Vancouver

Sandhu DS, Acharya S, Patel D, Gopi G, Kaur M, Patil S, et al. Abstract 17868: The Global Economic Footprint of Cardiomyopathy and Myocarditis: Rising Welfare Losses Across 187 Countries. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.17868

BibTeX
@article{Sandhu2026,
  author = {Sandhu, Damanpartap singh and Acharya, Sankalp and Patel, Dhruvin and Gopi, Gokul and Kaur, Mandeep and Patil, Shrusty and patel, jimik and PATEL, JUHI and DESAI, HARDIK D},
  title = {Abstract 17868: The Global Economic Footprint of Cardiomyopathy and Myocarditis: Rising Welfare Losses Across 187 Countries},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.17868}
}
Kostenlos starten →